Please wait

 

Exhibit 107.1

CALCULATION OF FILING FEE TABLE

FORM S-8

(Form Type)

RHYTHM PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in its Charter)

Table I: Newly Registered Securities

 

Plan   Security
Type		   Security
Class
Title		   Fee
Calculation
Rule		   Amount
Registered1		     Proposed
Maximum
Offering Price
Per Unit		     Maximum
Aggregate
Offering
Price		     Fee Rate   Amount of
Registration
Fee		  
2017 Incentive Award Plan   Equity   Common Stock, par value $0.001 per share   Rule 457(c)
and 457(h)		     2,264,497 2    $ 24.91 3    $ 56,408,620.27     $110.20 per million dollars   $ 6,216.23  
    Total Offering Amounts                   $ 56,408,620.27         $ 6,216.23  
    Total Fee Offsets                               $ —  
    Net Fee Due                               $ 6,216.23  

 

1 In accordance with Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued under the Rhythm Pharmaceuticals, Inc. 2017 Incentive Award Plan (the “Incentive Plan”) to prevent dilution resulting from stock splits, stock dividends or similar transactions. In addition, pursuant to Rule 416(c) under the Securities Act, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the Incentive Plan.
2 Consists of 2,264,497 shares of Common Stock that may become issuable under the Incentive Plan pursuant to its terms.
3 Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Select Market on February 24, 2023.